- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06668701
Evaluation of the Naturalistic User Experience of the Website "ich Bin Alles"
Evaluation of the Naturalistic User Experience of the Website "ich Bin Alles" - an Information Platform for Children and Adolescents with and Without Depression and Their Relatives
Study Overview
Status
Intervention / Treatment
Detailed Description
Depressive disorders are among the most common mental illnesses in children and adolescents and were already on the rise before the COVID-19 pandemic. This trend has been further exacerbated by the pandemic. Depression in adolescents is associated with particularly serious consequences, such as school and social problems, increased risk of suicide and impaired mental health in adulthood. If depression persists, the risk of chronification increases and continuous school attendance or continuation of vocational training is more difficult. The longer a depressive illness is not (effectively) treated, the lower the likelihood of remission and the higher the risk of chronification with further depressive episodes over the course of the illness. Although there are effective forms of treatment, in Germany only around 12% of adolescents with increased symptoms of depression seek professional treatment. The main barriers for adolescents to seek professional help include, for example, individual factors (low knowledge of mental disorders), social factors (e.g., perceived social stigmatisation) and systemic and structural barriers (e.g., limited access to professional help). In order to meet the need for action in a timely manner that meets the needs of the target group, the Department of Child and Adolescent Psychiatry of the Hospital of the LMU Munich and the Beisheim Foundation launched the innovative digital information portal "ich bin alles" ("I am everything"; www.ich-bin-alles.de) on depression and mental health in youth in 2021. Due to a sharp increase in online health information in recent years, the quality of this information and information portals has increasingly become the centre of attention. A review of the quality of mental health information websites found that many of the websites had shortcomings in terms of transparency, presentation and accuracy of content. These limitations were confirmed in a more recent study of depression websites. The comprehensibility of the content is also often limited, especially for users with a lower level of education and/or health literacy.
Due to the high relevance of comprehensively evaluating web-based information services on mental health and mental illness, the aim of this study is to use established methods to learn more about the visitors of "ich bin alles" and their user experience. This study will build on the approach of previous studies on website evaluation, which usually follow a multi-method approach: The evaluation of website analyses using tools such as Matomo; as well as an online questionnaire. The study is intended to provide clues as to whether the "ich bin alles" information platform is a useful and trustworthy source of information for the target groups. The information obtained is of central importance for potential adaptations and optimizations of the "ich bin alles" website. Another aim of this study is to determine whether "ich bin alles" can actually reach its desired target groups. The results of the data collection also provide an important basis for future approaches aimed at informing children, young people and their parents about mental health issues and mental illness in a way that is appropriate for the target group.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Ellen Greimel, Prof. Dr.
- Phone Number: +4989 4400 56952
- Email: Ellen.Greimel@med.uni-muenchen.de
Study Contact Backup
- Name: Sara Kaubisch
- Phone Number: +49 89 4400 56919
- Email: sara.kaubisch@med.uni-muenchen.de
Study Locations
-
-
Bavaria
-
Munich, Bavaria, Germany, 80336
- Recruiting
- LMU University Hospital
-
Contact:
- Ellen Greimel, Prof. Dr.
- Phone Number: +4989 4400 56952
- Email: Ellen.Greimel@med.uni-muenchen.de
-
Contact:
- Sara Kaubisch
- Phone Number: +49 89 4400 56919
- Email: sara.kaubisch@med.uni-muenchen.de
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- 40 seconds website-use
Exclusion Criteria:
- no exclusion criteria
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The characteristics of the people who are interested in "ich bin alles" (i.e. the users) - Assessed via self-designed questionnaire
Time Frame: post (40 seconds after Website-use)
|
post (40 seconds after Website-use)
|
|
Perception of the users of website content - Assessed via WEB-CLIC-S
Time Frame: post (40 seconds after Website-use)
|
post (40 seconds after Website-use)
|
|
Perceived Website Usability - Assessed via Perceived Website Usability - German
Time Frame: post (40 seconds after Website-use)
|
post (40 seconds after Website-use)
|
|
Visual Aesthetics of Website - Assessed via Visual Aesthetics of Website Inventory - Short
Time Frame: post (40 seconds after Website-use)
|
post (40 seconds after Website-use)
|
|
Overall impression - assessed via a single item (school grade)
Time Frame: post (40 seconds after Website-use)
|
post (40 seconds after Website-use)
|
|
Intentions to act - Assessed via Scale assessing the intention to revisit the website
Time Frame: post (40 seconds after Website-use)
|
post (40 seconds after Website-use)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
specific data collected for "ich bin alles" with Matomo
Time Frame: 45 months (from launch of the website until anticipated study completion)
|
Title of the pages accessed (page title)
|
45 months (from launch of the website until anticipated study completion)
|
|
specific data collected for "ich bin alles" with Matomo
Time Frame: 45 months (from launch of the website until anticipated study completion)
|
Location of the users: Country, region, city, approximate latitude and longitude (geolocation)
|
45 months (from launch of the website until anticipated study completion)
|
|
specific data collected for "ich bin alles" with Matomo
Time Frame: 45 months (from launch of the website until anticipated study completion)
|
Number of the website users
|
45 months (from launch of the website until anticipated study completion)
|
|
specific data collected for "ich bin alles" with Matomo
Time Frame: 45 months (from launch of the website until anticipated study completion)
|
How the users accessed the website (e.g.
Google search or Social Media link)
|
45 months (from launch of the website until anticipated study completion)
|
|
specific data collected for "ich bin alles" with Matomo
Time Frame: 45 months (from launch of the website until anticipated study completion)
|
How much time the users spend on the website
|
45 months (from launch of the website until anticipated study completion)
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Gerd Schulte-Körne, Prof. Dr., Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, LMU University Hospital
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 24-0201 KB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.